Struggle Over Online Cancer Service Spurs Larger Medical Ethics Debate

PUSHED ASIDE: E. Loren Buhle was a cofounder of OncoLink, but later battled with Penn administrators over its content. University's move to rein in a junior professor raises questions about responsibility for patient-care advice and the appropriate role of experts on the Internet. A recent struggle for control of a popular Internet cancer-information service at the University of Pennsylvania represents more than just an M.D.-vs.-Ph.D. rivalry in an academic department, according to physicians

Written byFranklin Hoke
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


PUSHED ASIDE: E. Loren Buhle was a cofounder of OncoLink, but later battled with Penn administrators over its content.

University's move to rein in a junior professor raises questions about responsibility for patient-care advice and the appropriate role of experts on the Internet.
A recent struggle for control of a popular Internet cancer-information service at the University of Pennsylvania represents more than just an M.D.-vs.-Ph.D. rivalry in an academic department, according to physicians, researchers, social scientists, and cancer patients and their families. The incident also brings to light vexing ethical issues that promise to become more prominent as the flow of medical information on the Internet increases, they contend.

These larger questions have arisen in the dispute over OncoLink, which posts research and clinical oncology literature, as well as a wide range of patient-support information. Concerns include what responsibility providers have for information they disseminate and what the appropriate role ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies